Stephanie D. Taylor
Investor at Syridex Bio
About
Executive and subject matter expert in Health Economics and Outcomes Research and market access, currently driving portfolio optimization for J&J MedTech and formerly Executive Director at Eli Lilly. Holds a PhD in Pharmacy from Ohio State University.
Colleagues at Syridex Bio
Anindya Roychowdhury
Investor at Syridex Bio
Ben Duster
Investor at Syridex Bio
Charles Corpening
Investor at Syridex Bio
Christopher Whitfield
Advisory Partner at Syridex Bio
Joshua Adeoye
Principal at Syridex Bio
Kamil Ali-Jackson
Investor at Syridex Bio
Owen May
Investor at Syridex Bio
Squire Servance
Founder and Managing Partner at Syridex Bio